Wed, April 10, 2024 12:00 PM - EST

Regulating Medical AI – Staying Safe in the Fast Lane

Register now

In a world where technological advances outpace the speed of policy and regulation, how do we ensure cutting-edge AI technologies are safe, and that regulatory requirements enable, rather than inhibit, the potential benefits of AI?

This event will feature a lively discussion on the regulation of AI – where current regulation works and where it falls short of ensuring novel AI technologies are safe for medical use. NEJM AI editors will speak with regulatory experts, scientists, and policymakers about what challenges lie ahead for new AI technologies as well as how scientific evidence, ethical principles, regulation, and regulatory science can enable, and even accelerate, the positive of AI impact on patients.

Join us to learn about:

  • International approaches and alignment in AI regulation
  • Regulating AI as a medical device
  • Post-market surveillance and monitoring of ongoing AI performance
  • And more!

Jeff Naveda, MBA, CQA, RAC(US)

Vice President of Quality and Regulatory Affairs,